Our guide on microdosing GLP-1 for autoimmune conditions explores gentler approaches for this population
Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses
Although the American College of Obstetricians and Gynecologists (ACOG) has yet to set guidelines on this, providers are pushing for patience
Syeda USA, Battillo D, Visaria A, Malin SK
20-22 Although a reduction in the progression to end-stage kidney disease is yet to be definitively demonstrated, evidence for this class of medication having cardio-kidney protective effects in people with type 2 diabetes is accumulating
Numerous lawsuits argue that Novo Nordisk should have better communicated the risks of severe gastrointestinal side effects, including gastroparesis